Model Organisms in the Fight against Muscular Dystrophy: Lessons from Drosophila and ZebrafishReportar como inadecuado




Model Organisms in the Fight against Muscular Dystrophy: Lessons from Drosophila and Zebrafish - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

1

GReD Genetics, Reproduction and Development laboratory, INSERM U1103, CNRS UMR6293, University of Clermont-Ferrand, 28 place Henri-Dunant, 63000 Clermont-Ferrand, France

2

Department of Animal Developmental Biology, Institute of Experimental Biology, University of Wroclaw, 21 Sienkiewicza Street, 50-335 Wroclaw, Poland



These authors contributed equally to this work.





*

Author to whom correspondence should be addressed.



Academic Editor: Leonidas A. Phylactou

Abstract Muscular dystrophies MD are a heterogeneous group of genetic disorders that cause muscle weakness, abnormal contractions and muscle wasting, often leading to premature death. More than 30 types of MD have been described so far; those most thoroughly studied are Duchenne muscular dystrophy DMD, myotonic dystrophy type 1 DM1 and congenital MDs. Structurally, physiologically and biochemically, MDs affect different types of muscles and cause individual symptoms such that genetic and molecular pathways underlying their pathogenesis thus remain poorly understood. To improve our knowledge of how MD-caused muscle defects arise and to find efficacious therapeutic treatments, different animal models have been generated and applied. Among these, simple non-mammalian Drosophila and zebrafish models have proved most useful. This review discusses how zebrafish and Drosophila MD have helped to identify genetic determinants of MDs and design innovative therapeutic strategies with a special focus on DMD, DM1 and congenital MDs. View Full-Text

Keywords: muscular dystrophies; animal models; Drosophila; zebrafish; pathophysiology; therapeutic screens muscular dystrophies; animal models; Drosophila; zebrafish; pathophysiology; therapeutic screens





Autor: Emilie Plantié 1,†, Marta Migocka-Patrzałek 2,†, Małgorzata Daczewska 2 and Krzysztof Jagla 1,*

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados